Naproxen
- Product NDC
- 82982-013
- 11-digit product format
- 829820013
- Labeler code
- 82982
- Product ID
- 82982-013_198d02db-5547-8b96-e063-6294a90af8cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Pharmasource Meds, LLC
- Application
- ANDA212517
- Marketing category
- ANDA
- Marketing start
- 2023-02-02
- Marketing end
- 2026-05-31
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82982-013-60 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 82982-013 | NAPROXEN TABLET [PHARMASOURCE MEDS, LLC] | 2 | Current NDC, 1 package rows | 20240602_f3bcad49-561b-063c-e053-2a95a90ac10d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 82982-013-60 | 82982001360 | 60 TABLET in 1 BOTTLE (82982-013-60) | 60 tablet | 2023-02-02 | 2026-05-31 | No | No | Historical |